Issued Patents 2019
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10513703 | Hepatitis B virus (HBV) iRNA compositions and methods of use thereof | Laura Sepp-Lorenzino, Vasant Jadhav, Martin Maier, Stuart Milstein, Muthiah Manoharan +1 more | 2019-12-24 |
| 10494632 | Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof | James Butler, Kevin Fitzgerald, Brian Bettencourt, Huilei Xu | 2019-12-03 |
| 10472628 | Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene | Antonin de Fougerolles, Tatiana Novobrantseva | 2019-11-12 |
| 10407679 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | Kevin Fitzgerald, William Querbes, James Butler, Stephanie Williams, Abigail Liebow +4 more | 2019-09-10 |
| 10400238 | Polynucleotide agents targeting complement component C5 and methods of use thereof | — | 2019-09-03 |
| 10370666 | Ketohexokinase (KHK) iRNA compositions and methods of use thereof | Kevin Fitzgerald, Brian Bettencourt, Jennifer Willoughby | 2019-08-06 |
| 10344278 | Polynucleotide agents targeting Serpinc1 (AT3) and methods of use thereof | — | 2019-07-09 |
| 10287582 | Organic compositions to treat HSF1-related diseases | Satyanarayana Kuchimanchi, Stuart Milstein, Markus Warmuth, Wenlai Zhou, Ping Zhu +1 more | 2019-05-14 |
| 10240152 | Compositions and methods for inhibiting expression of transthyretin | Dinah Wen-Yee Sah, Rene Alvarez, Stuart Milstein, Qingmin Chen | 2019-03-26 |
| 10238749 | Angiotensinogen (AGT) iRNA compositions and methods of use thereof | Donald C. Foster, Brian Bettencourt, Klaus Charisse, Satyanarayana Kuchimanchi, Martin Maier +1 more | 2019-03-26 |
| 10231988 | Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof | Kevin Fitzgerald | 2019-03-19 |